ArticleIn vivo (Athens, Greece)
Risk of Hidradenitis Suppurativa in Patients With Carpal Tunnel Syndrome: A Population-based Cohort Study.
Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Carpal Tunnel Syndrome Is Associated with Increased Risk of Fibromyalgia: A Retrospective Cohort Study.Life (Basel, Switzerland) · 2026Article
- Carpal tunnel syndrome as risk factor for subsequent development of irritable bowel syndrome: a retrospective cohort study.Scientific reports · 2026Article
- Risk of systemic rheumatic diseases in people with irritable bowel syndrome: a global-federated cohort analysis.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimCarpal tunnel syndrome (CTS) and hidradenitis suppurativa (HS) are chronic inflammatory conditions that significantly affect quality of life. While both disorders have distinct manifestations, they share common risk factors such as obesity and systemic inflammation. This study aimed to evaluate whether CTS is associated with an increased risk of HS. PATIENTS AND
methodsWe conducted a retrospective cohort study using data from the TriNetX Global Health Research Network. Adults diagnosed with CTS were matched 1:1 with controls without CTS, based on age, sex, race, body mass index (BMI), comorbidities, socioeconomic status, and healthcare utilization. Individuals with prior HS or cancer were excluded. The primary outcome was new-onset HS, identified by ICD-10 codes. Hazard ratios (HRs) with 95% confidence intervals (CIs). Sensitivity analyses incorporated varied wash-out periods, alternative CTS definitions, and different follow-up durations.
resultsAfter matching, 493,181 patients were included in each group. Over a 15-year follow-up period, patients with CTS showed a significantly higher risk of HS (HR=1.739; 95%CI=1.617-1.871). Sensitivity analyses validated the robustness of the results, with HRs ranging from 1.647 (95%CI=1.572-1.726) to 2.142 (95%CI=1.979-2.318) across different models. In stratified analyses, the association remained significant across all subgroups. Among males, the HR was 1.249 (95%CI=1.042-1.498), whereas among females, it was 1.739 (95%CI=1.606-1.884). Patients aged 18-64 years had an HR of 1.772 (95%CI=1.642-1.913), while those aged ≥65 years had an HR of 1.479 (95%CI=1.146-1.907).
conclusionCTS is significantly associated with an increased risk of HS. These findings suggest a possible shared inflammatory pathway, and dermatologic comorbidities in CTS patients should be carefully considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.